All Insights

Intellectual property

Judicial changes strengthen English Patents Court

Recent high-profile appointments and developments will bolster the UK's reputation as a forum for litigating complex patent disputes

Life Sciences and Healthcare

Breakthrough for digital healthcare in Belgium as scheme launches to reimburse mobile health apps

Reimbursement for patients' app purchases is important next step for rollout of the mHealthBelgium platform

Life Sciences and Healthcare

A new bag of tricks? Obvious if it could have been done before (says the Patents Court)

In order to establish obviousness for the purposes of a patent application, it is enough to show that the idea

Intellectual property

Illuminating insufficiency: the English Patents Court examines "Regeneron ranges"

In applying the insufficiency principles laid down in Regeneron, the High Court highlights some key considerations for patentees looking to

Brexit

Brexit Business Brief | Getting to grips with the Trade and Cooperation Agreement

Our regular newsletter looking at Brexit developments in a legal and business context

IT and data

UK and EU data protection post-Brexit: a brief guide

At 23:00 on 31 December 2020, the Brexit transition period came to end and a new UK data protection regime

Intellectual property

How to instruct experts in patent cases correctly

The recent decision of Mr Justice Meade in Fisher & Paykel v Flexicare is yet another warning to patent practitioners

Digitalisation

Cybersecurity Asia: People's Republic of China to treat data security as matter of national security

Beijing is evolving its cybersecurity approach, after unveiling draft laws that promise to elevate data protection into the domain of

Life Sciences and Healthcare

What's in a name? Help your medicine go down well with consumers and regulators

The choice of the right brand name for a medicine or pharmaceutical product is essential for establishing a lasting market